Fluorofenidone

氟非尼酮

Report date: 2025/03/18 17:01:59
NME

Base Information

Drug NameFluorofenidone
Drug Alias NameAKF-PD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 γ mitogen-activated protein kinase inhibitorsTransforming growth factor beta 1 inhibitors
TargetsP38 γ mitogen-activated protein kinaseTransforming growth factor beta 1
Therapy Area/IndicationsLiver CirrhosisHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHainan Haiyao Co LtdCentral South UniversityDierepharma HK Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCentral South UniversityHaikou Pharmaceutical Factory Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A